国际皮肤性病学杂志    2003 29 (1): 48-50   ISSN: 2096-5540  CN: 32-1880/R   人类乳头瘤病毒感染的免疫逃逸机制 刘泽虎, 刘贞富 华中科技大学同济医学院附属协和医院皮肤性病科, 武汉 430022 收稿日期 2002-02-04  修回日期 null  网络版发布日期 null 参考文献  [1] Stanley M.The immunology of genital human papilloma virus infection.Eur J Dermatol,1998,8(7 Suppl);8-12. [2] Frazer IH,Thomas R,Zhou J,et al.Potential strategies utilised by papillomavirus to evade host immunity.Immunol Rev,1999,168:131-142. [3] Li S,Labrecque S,Gauzzi MC,et al.The human papilloma virus(HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.Oncogene,1999,18(42);5727-5737. [4] Barnard P,McMillan NA.The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.Virology,1999,259(2);305-313. [5] Goodbourn S,Didcock L,Randall RE.Intefferons:cell signalling,immune modulation,antiviral response and virus countermeasures.J Gen Virol,2000,81(Pt 10);2341-2364. [6] Cho YS,Kang JW,Cho M,et al.Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18.FEBS Lett,2001,501(2-3);139-145. [7] Lee SJ,Cho YS,Cho MC,et al.Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells.J Immunol,2001,167(1);497-504. [8] Georgopoulos NT,Proffitt JL,Blair GE.Transcriptional regulation of the major histocompatibility complex(MHC)class I heavy chain,TAP1 and LMP2 genes by the human papillomavims(HPV)type 6b,16 and 18 E7 oncoproteins.Oncogene,2000,19(42):4930-4935. [9] Vambutas A,DeVoti J,Pinn W,et al.Interaction of human papillomaviras type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport.Clin Immunol et al.2001,101(1);94-99. [10] Alcami A,Koszinowski UH.Viral mechanisms of immune evasion.Immunol Today,2000,21(9);447-455. [11] Banchereau J,Steinman RM.Dendritic cells and the control of immunity.Nature,1998,392(6673);245-252. [12] Coleman N,Birley HD,Renton AM,et al.Immunological events in regressing genital warts.Am J Clin Pathol,1994,102(6);768-774. [13] Hart DN.Dendritic cells:unique leukocyte populations which control the primary immune response.Blood,1997,90(9);3245-3287. [14] Cumberbatch M,Dearman R J,Kimber I.Interleukin 1 beta and the stimulation of Langerhans cell migration:comparisons with tumour necrosis factor alpha.Arch Dermatol Res,1997,289(5);277-284. [15] Mota F,Rayment N,Chong S,et al.The antigen-presenting environment in normal and human papillomavirus(HPV)-related premalignant cervical epithelium.Clin Exp Immunol,1999,116(1);33-40. [16] Zambruno G,Cossarizza A,Zacchi V,et al.Functional intercellular adhesion molecule-3 is expressed by freshly isolated epidermal Langerhans cells and is not regulated during culture.J Invest Dermatol,1995,105(2):215-219. [17] Wei LH,Kuo ML,Chen CA,et al.Interleukin-6 in cervical cancer:the relationship with vascular endothelial growth factor.Gynecol Oncol,2001,82(1);49-56. [18] E1-Sherif AM,Seth R,Tighe PJ,et al.Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.J Pathol,2001,195(2);179-185. [19] Grassegger A,Rollinger-Holzinger I,Zelger BW,et al.Spontaneous or interferon-gamma-induced T-cell infiltration,HLA-DR and ICAM-1 expression in genitoanal warts are associated with Thl or mixed Th1/Th2 cytokine mRNA expression profiles.Arch Dermatol Res,1997,289(5);243-250. [20] Goerdt S,Orfanos CE.Other functions,other genes:alternative activation of antigen-presenting cells.Immunity,1999,10(2):137-142. [21] Rudolf MP,Fansch SC,Da Silva DM,et al.Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro.J Immunol.2001,166(10):5917-5924. 通讯作者: